Menu Search
Equities

Intrasense SA

I8S:STU

Intrasense SA

Actions
  • Price (EUR)0.2510
  • Today's Change-0.015 / -5.64%
  • Shares traded0.00
  • 1 Year change-30.28%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Intrasense SA is a French-based company, which specializes in designing and developing software for two-dimensional (2D) and three-dimensional (3D) viewing and analyzing medical images. The Company’s activities are divided into three divisions: sales of software for viewing and analyzing medical images; development of peripheral solutions;and supply of services. Its product portfolio comprises the Myrian line products are integrated into existing medical devices, such as Cr, Ultra sound and Nuclear imagining. Myrian Solutions are used for reconstruction of images from the Computed tomography(CT) scan, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography scans, marketed under Myrian brand. The peripheral solutions provide materials for viewing digital images in the operating room, as well as various equipment, including printing servers and workstations, among others. It offers also support, maintenance, as well as software rental and installation services for its products.

  • Revenue in EUR (TTM)2.33m
  • Net income in EUR-3.89m
  • Incorporated2004
  • Employees74.00
  • Location
    Intrasense SA1231 Avenue du mondial 98MONTPELLIER 34000FranceFRA
  • Phone+33 467130130
  • Fax+33 467130132
  • Websitehttps://intrasense.fr/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.